Better Buy: Pfizer vs. Johnson & Johnson
Two of the biggest healthcare stocks on the market in terms of market cap haven't delivered big returns for investors in recent years. Both Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ) have lagged well behind the S&P 500.
But the dynamics are changing for both companies. Which stock is likely to be the biggest winner for investors over the next decade? Here's how Pfizer and Johnson & Johnson stack up against each other.
Image source: Getty Images.
Source Fool.com
